Diabetes is a chronic disease that involves an elevated level of blood sugar. It has a high risk of causing heart disease due ...

The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

Can telemedicine and exercise apps improve the health of people with type 2 diabetes and coronary heart disease? A large ...

Groundbreaking research reveals how common diabetes medications might offer unprecedented protection against heart attacks ...

Learn how chronic kidney disease and diabetes accelerate heart risk, with new research revealing early warning signs.

A new study published in the Journal of the Society for Cardiovascular Angiography & Interventions has revealed a lower risk ...

Cardiovascular diseases claim more lives in the U.S. than all forms of cancer and accidental deaths combined, according to ...

Discover how regular exercise can strengthen your heart, regulate blood sugar and lower heart disease risk for those with ...

To maintain a healthy heart, researchers say people should focus on diet and exercise, limit alcohol, manage stress, get ...

Dialysis Centers used data from the Centers for Disease Control and Prevention to examine the prevalence of chronic diseases ...

Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...